仅因子宫内膜异位症与其他不孕原因接受辅助生殖技术治疗后的围产期和婴儿结局:一项数据链接队列研究
基于澳大利亚新南威尔士州2010-2017年29,152例辅助生殖技术(ART)单胎出生数据,评估仅子宫内膜异位症与其他不孕原因母亲的围产期和婴儿结局差异。调整混杂因素后,子宫内膜异位症整体与结局无总体关联,但深部子宫内膜异位症早产(aRR 1.75)和小于胎龄儿(aRR 1.58)风险升高。
要点
- ART单胎中19.9%母亲诊断为子宫内膜异位症,仅子宫内膜异位症占23.8%。
- 整体子宫内膜异位症与围产期及婴儿结局无总体关联。
- 深部子宫内膜异位症早产aRR 1.75(95%CI 1.12-2.75),小于胎龄儿aRR 1.58(95%CI 1.05-2.37)。
核心结论
- 仅子宫内膜异位症与其他不孕原因相比,ART单胎的围产期和婴儿结局总体相当。
- 深部子宫内膜异位症患者ART后早产和小于胎龄儿风险可能升高,临床医生应知晓这些潜在风险。
研究设计与样本
- 基于人群的数据链接队列研究,纳入澳大利亚新南威尔士州2010-2017年29,152例ART单胎出生,来自24,116名母亲。
主要发现
- 29,152例ART单胎中,19.9%(5,806/29,152)母亲诊断为子宫内膜异位症;其中23.8%(1,379/5,806)为仅子宫内膜异位症,76.2%(4,427/5,806)为子宫内膜异位症合并其他不孕原因。
- 21,795/29,152(约四分之三)出生来自无子宫内膜异位症母亲,5.3%(1,551/29,152)来自不孕原因未注明母亲。
- 调整母亲年龄、产次、ART治疗特征、妊娠期高血压和糖尿病、吸烟及社会经济状况后,子宫内膜异位症与围产期及婴儿结局无总体关联。
- 与无子宫内膜异位症女性相比,深部子宫内膜异位症者早产风险升高(调整相对风险1.75;95%置信区间1.12-2.75),小于胎龄儿风险升高(调整相对风险1.58;95%置信区间1.05-2.37)。
临床怎么用
- 作者认为,对于接受ART的深部子宫内膜异位症患者,早产和小于胎龄儿风险可能增加,临床医生应知晓这些潜在风险。
局限性
- 原文指出需要更大规模的研究来确认与子宫内膜异位症表型相关的差异风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate whether perinatal and infant outcomes differ between singleton births after assisted reproductive technology (ART) in women with endometriosis alone and those with other causes of infertility. DESIGN: Population-based data linkage cohort study. SUBJECTS: A total of 29,152 ART-conceived singleton births from 24,116 mothers, 2010-2017, New South Wales, Australia. EXPOSURE: Endometriosis, identified from the Australian and New Zealand Assisted Reproduction Database, hospital admissions, and dispensed medication records. The causes of infertility were categorized as follows: endometriosis alone; endometriosis plus other cause(s) of infertility; infertility other than endometriosis; and unstated cause of infertility. The endometriosis alone group was further classified using International Classification of Diseases, Tenth Revision, codes (N80.0-N80.9) into superficial, ovarian, deep, and other endometriosis. MAIN OUTCOME MEASURES: Perinatal and infant outcomes, included preterm birth (<37 weeks), very preterm birth (<32 weeks), small for gestational age (SGA), large for gestational age, admission to neonatal intensive care unit, perinatal death, and infant hospitalization up to 2 years of age. Generalized estimating equations were used to investigate independent associations between endometriosis and study outcomes. RESULTS: Of the 29,152 ART-conceived singleton births, 19.9% (5,806/29,152) were from mothers with a diagnosis of endometriosis. Among these, 23.8% (1,379/5,806) were from mothers with an endometriosis alone diagnosis, and 76.2% (4,427/5,806) were from mothers with endometriosis plus other cause(s) of infertility. Three quarters (21,795/29,152) of births were from mothers without endometriosis and 5.3% (1,551/29,152) were from mothers with an unstated cause of infertility. After adjusting for maternal age at the time of birth, parity, ART treatment characteristics, gestational hypertension and diabetes, smoking, and socioeconomic status, there was no overall association between endometriosis and perinatal and infant outcomes. However, compared with women without endometriosis, those with deep endometriosis had a higher risk of preterm birth (adjusted relative risk, 1.75; 95% confidence interval, 1.12-2.75) and SGA (adjusted relative risk, 1.58; 95% confidence interval, 1.05-2.37). CONCLUSION: Reassuringly, perinatal and infant outcomes are generally comparable for ART-conceived infants born to mothers with endometriosis alone and those with other causes of infertility when considered as a singular disease entity. Larger studies are needed to confirm the differential risk associated with endometriosis phenotypes; however, for patients with deep endometriosis undergoing ART, the risks of preterm birth and SGA may be increased. Clinicians should be aware of these potential risks.
引用
- Zhang X, Chambers GM, Venetis C, et al. Perinatal and infant outcomes after assisted reproductive technology treatment for endometriosis alone compared with other causes of infertility: a data linkage cohort study. Fertil Steril. 2024. PMID: 39672363. doi:10.1016/j.fertnstert.2024.12.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。